Name: Tissue-Specific Estrogen Action: Novel Mechanisms, Novel Ligands, Novel Therapies (Ernst Schering Foundation Symposium Proceedings, 2006 (en Inglés)
SKU: 62114824
Price: 590027.00 COP
Availability: InStock
Author: Korach Kenneth S.,Wintermantel Tim
ISBN: 9783642421037

portada Tissue-Specific Estrogen Action: Novel Mechanisms, Novel Ligands, Novel Therapies (Ernst Schering Foundation Symposium Proceedings, 2006 (en Inglés)

Tissue-Specific Estrogen Action: Novel Mechanisms, Novel Ligands, Novel Therapies (Ernst Schering Foundation Symposium Proceedings, 2006 (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Korach Kenneth S.,Wintermantel Tim

Idioma

Inglés

N° páginas

181

Encuadernación

Tapa Blanda

ISBN13

9783642421037

N° edición

2007th

Tissue-Specific Estrogen Action: Novel Mechanisms, Novel Ligands, Novel Therapies (Ernst Schering Foundation Symposium Proceedings, 2006 (en Inglés)

Korach Kenneth S.,Wintermantel Tim (Autor) · Springer · Tapa Blanda

Libro Nuevo Importado

Envío: 22 a 26 días háb.

$ 983.378$ 590.027

-40%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 590.027

¡Envío Gratis! Llega entre el 10 Dic y el 17 Dic a Bogota, Cundinamarca. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Tissue-Specific Estrogen Action: Novel Mechanisms, Novel Ligands, Novel Therapies (Ernst Schering Foundation Symposium Proceedings, 2006 (en Inglés)"

Nuclear hormone receptors are not only important drug targets, but have also been the focus of decades of active and highly insightful research. Ten years ago, a review on nuclear receptors was entitled "The Second Decade" and a special issue of Molecular Endocrinology in 2005 dealt with the results of these research efforts. The consensus from nuclear receptor research was of course that the signaling pathways mediated by these receptors warrant further research, even though in principle they appeared to represent the most immediate, seemingly simple signaling pathway from hormone (ligand) binding to gene expression changes. In nuclear receptor molecular biology, estrogen receptor research has additional unique facets: since the discovery of ethinyl estradiol by Inhoffen and Hohlweg in the laboratories of Schering AG in the 1930s--and therefore several decades longer than nuclear receptor - searchitself--estrogenreceptorshavebeentargetsofwidelyused, orally administered drugs. Thus, accumulating clinical experience on estrogen action in vivo helps to support the progress in molecular biological research.